Council for Innovation Promotion

Publish Date
Council for Innovation Promotion, UC Irvine, and Orange County Business Council Host Discussion on OC Innovation

IRVINE, CA (January 29, 2026) — Today, Thursday, January 29, from 10:00 AM to 1:00 PM PT, the Council for Innovation Promotion...

Debunking common myths in the SEP patent pool debate

Patent pools are a time-tested approach to licensing standard-essential patents, also known as SEPs. These collaborative arrangements allow implementers to conveniently obtain...

Public Comments
C4IP Comments RE: The 2026 Special 301 Review (USTR-2025-0243)
Inventor Spotlight: George de Mestral

C4IP is recognizing George de Mestral (1907-1990), whose invention of Velcro fasteners has become an integral part of products from clothing to...

How to avoid buying fake sports merchandise ahead of Super Bowl Sunday
FOX 13
Hearings & Markups: Trade Subcommittee Hearing on Maintaining American Innovation and Technology Leadership
JD Supra
Fact Check: Debunking The Myth of “Evergreening” and “Patent Thicketing”

Former Federal Trade Commission Chair Lina Khan recently appeared on The Weekly Show with Jon Stewart, where their discussion revived familiar tropes...

Former USPTO director urges legislators to pass patent reform laws, bolster international IP enforcement
VitalLaw
Witnesses Urge Action on Digital Trade
MeriTalk
Iancu Urges House Trade Subcommittee to Address Weakening of U.S. IP Rights By America’s Trading Partners
IPWatchdog
Artificial Intelligence And Patent Law
The Eurasia Review
Council for Innovation Promotion Responds to Passage of EU General Pharmaceutical Legislation

WASHINGTON (January 8, 2026) — The European Council and Parliament recently finalized the General Pharmaceutical Legislation (GPL), a sweeping package of legislative...

News:

News:

Ex-USPTO Directors Want Vidal To Withdraw Disclaimer Plans,

05/28/2024

News:

News:

Quintet of Ex-Patent Office Officials Slam Proposed Rulemaking,

05/28/2024

Blog:

Blog, Fact Checks:

Fact Check: Price Controls Would Not Make Diabetes Treatments More Accessible,

05/24/2024

News:

News:

C4IP Urges Senate Judiciary to Ignore Common Myths About Drug Patents,

05/23/2024

News:

News:

Group chaired by former USPTO directors questions office’s AI guidance over ‘human contribution’,

05/21/2024

Resources:

Resources:

C4IP Letter to Senate Judiciary Committee on 5/21 Hearing on Drug Prices,

05/20/2024

News:

News:

Industry Reacts to USPTO Guidance on Using AI to Innovate,

05/20/2024

Resources:

Resources:

C4IP Letter to Senate Commerce, Science, & Transportation Committee on the Invent Here, Make Here Act of 2023,

05/15/2024

News:

News:

USPTO Guidance On AI And Patents Draws Worry And Praise,

05/14/2024

Resources:

Resources:

C4IP Comments RE: Inventorship Guidance for AI-Assisted Inventions (PTO-P-2023-0043),

05/13/2024

Blog:

Blog:

Inventor Spotlight: William Coolidge,

05/13/2024

Resources:

Resources:

C4IP Comments RE: Unlocking the Full Potential of Intellectual Property by Translating More Innovation to the Marketplace (PTO-C-2024-0004),

05/13/2024

Scroll to Top